pharmacie et médicaments – Remboursement du médicament Combodart

This written question seeks clarification regarding the reimbursement status of Combodart, a medication used to treat enlarged prostates. The procedure aims to understand the criteria used by health authorities to determine whether the state will cover the cost of this specific drug for patients. This affects patients requiring prostate treatment and healthcare providers in France who rely on state reimbursement to make medications affordable.